Haiping Jiang

California Institute for Regenerative Medicine — United States

Medicine · Health Sciences

19h-index1.7kcitations86works2.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(13), Lung Cancer Treatments and Mutations(8), Gastrointestinal Tumor Research and Treatment(8), Cancer Immunotherapy and Biomarkers(7), Cancer Research and Treatments(6)

Publications86 total

Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907)
Gynecologic Oncology·2025· 2 cited
Inflammation awakens dormant cancer cells by modulating the epithelial–mesenchymal phenotypic state
Proceedings of the National Academy of Sciences·2025· 1 citedOpen Access
Initial results from a phase I study of the SHP2 inhibitor GH21 as monotherapy in patients with advanced solid tumors.
Journal of Clinical Oncology·2025
Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia
Open Medicine·2025· 1 citedOpen Access
Corrigendum: En Bloc Resection for Spinal Cord Hemangioblastomas: Surgical Technique and Clinical Outcomes
Journal of Neurological Surgery Part A Central European Neurosurgery·2024Open Access
Research on Wind Turbine Power Curve Anomaly Detection Technology Based on YOLOv8
2024
A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer
Scientific Reports·2024· 1 citedOpen Access
Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis
Stem Cell Reports·2024· 5 citedOpen Access
Neutrophil Extracellular Traps‐Inhibiting and Fouling‐Resistant Polysulfoxides Potently Prevent Postoperative Adhesion, Tumor Recurrence, and Metastasis
Advanced Materials·2024· 16 cited
Portective Role of Seleno-Amino Acid Against Inflammatory Bowel Disease via Ferroptosis Inhibition in Enteral Nutrition Therapy
SSRN Electronic Journal·2024Open Access
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
JAMA·2023· 303 citedOpen Access
En Bloc Resection for Spinal Cord Hemangioblastomas: Surgical Technique and Clinical Outcomes
Journal of Neurological Surgery Part A Central European Neurosurgery·2023· 2 citedOpen Access
1057P Long-term follow-up of a phase II study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) solid tumors
Annals of Oncology·2023Open Access
Nifuroxazide inhibits the growth of glioblastoma and promotes the infiltration of CD8 T cells to enhance antitumour immunity
International Immunopharmacology·2023· 7 cited
Sex differences in the scored Patient-Generated Subjective Global Assessment in 19,528 cancer patients
journal of nutritional oncology·2023Open Access
Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
Open Life Sciences·2023· 1 citedOpen Access
Contributors
Elsevier eBooks·2023
RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux
Frontiers in Oncology·2022· 21 citedOpen Access
Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study
Journal for ImmunoTherapy of Cancer·2022· 99 citedOpen Access
Nifuroxazide Inhibits the Growth of Glioblastoma and Promotes the Infiltration of Cd8 T Cells to Enhance Antitumour Immunity
SSRN Electronic Journal·2022· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Lisong Teng(7), Youqing Shen(5), Nong Xu(5), Yulong Zheng(5), Chenyu Mao(5), Junyi Ye(5), Haohao Wang(4), Jiong Qian(4), Nong Xu(4), Dongzhi Zhang(4), Lin Shen(3), Zhuxian Zhou(3), Jianbin Tang(3), Hongxia Xu(3), Zengqing Guo(3), Yuan Lin(3), Yingying Shi(3), Wen Hu(3), Yi Ba(3), Suyi Li(3)